Biosynex

Biosynex

Specializing in the design and distribution of rapid diagnostic tests worldwide, Biosynex enhances patient care with healthcare solutions. The Biosynex Group of companies include Chembio Diagnostics, rapid POC assays for HIV, COVID and the only FDA approved combo test for HIV & Syphilis; Qualigen Diagnostics FastPack, providing tests for prostate cancer, thyroid function, Testo and more; and ProciseDx, offering the first FDA cleared instrument for Therapeutic Drug Monitoring (TDM) for Infliximab and Adalimumab with results in less than 5 minutes.

OEM Products, COVID, HIV Testing, Infectious Disease Testing, Infectious Disease, Other, Influenza Testing, Near Patient Testing, Point of Care Testing, Rapid Tests, STD Testing, Therapeutic Drug Monitoring, Thyroid Testing, Urinalysis

No

Direct Sales, Distributor/Agent/Representative

United States